BLK vs XOM: Which Is the Better Buy?

Side-by-side comparison of BlackRock, Inc. and Exxon Mobil Corporation β€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-21.
BlackRock, Inc. Β· Financial Services
$1,069.78
+44.0% upside to fair value
High Conviction Grade A High Quality
VS
Exxon Mobil Corporation Β· Energy
$163.18
+10.3% upside to fair value
Med Conviction Grade B High Quality
QuantHub Verdict
BLK has more upside to fair value (+44.0%). These are model outputs β€” not personalized investment advice. See all research β†’
Valuation & Fundamentals
Metric BLK XOM
Current Price $1,069.78 $163.18
Fair Value Estimate $1,540.94 $179.98
Upside to Fair Value +44.0% +10.3%
Market Cap $165.8B $676.3B
Forward P/E β€” β€”
EV / EBITDA 15.9x 9.9x
Price / Sales 6.1x 1.9x
Price / FCF 71.5x 22.3x
Revenue Growth YoY +30.6% +44.1%
Gross Margin 55.7% 25.1%
Operating Margin 31.1% 10.7%
Return on Equity 11.7% 12.7%
Dividend Yield 2.09% 2.52%
FCF Yield 1.4% 4.49%
Analyst Consensus Strong Buy Hold
Investment Thesis
BLK β€” BlackRock, Inc.
BlackRock is the world's largest asset manager, overseeing $15.345 trillion in assets across ETFs, active strategies, alternatives, and the Aladdin investment-technology platform, serving institutional, intermediary, and individual clients globally. The business quality is high: TTM gross margin of 55.7%, operating margin of 31.1%, and net margin of 24.1% reflect the scalability of a fee-based mo…
XOM β€” Exxon Mobil Corporation
Exxon Mobil is the largest integrated oil and gas major in the United States, operating across Upstream exploration and production, Downstream refining and fuels marketing, and Chemical manufacturing, with roughly 57,900 employees and a portfolio that spans conventional crude and natural gas, LNG, petrochemicals, and early-stage carbon capture, hydrogen, and biofuels ventures. The business qualit…
Accumulation Zones
Metric BLK XOM
Zone Low $1,155.70 $134.98
Zone High $1,309.80 $152.98
In Buy Zone? Yes No
← BLK Research    XOM Research β†’    All Research